NADH (Reduced NAD+): What It Is and How the Pathway Works

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

"NAD+ reduced" points to a specific chemical idea: the reduced, electron-carrying form of nicotinamide adenine dinucleotide, usually written as NADH. It is one of the most-discussed molecules in the longevity conversation, yet it is often described vaguely. This article keeps it concrete — what the reduced form is, how the pathway cycles, and why your genes shape the terrain underneath it. For the wider collection of longevity explainers, visit our Education Hub.

Oxidized versus reduced: the core distinction

NAD exists in two interconverting states. NAD+ is the oxidized form; NADH is the reduced form that carries a pair of electrons. Cells constantly shuttle between the two as they extract energy from food, so the ratio between them is a meaningful signal of metabolic state rather than a fixed number. When people say "reduced NAD+," they are describing NADH's role as the loaded electron carrier in that cycle.

How the reduced form functions

NADH delivers electrons into the mitochondrial machinery that produces cellular energy, linking the breakdown of nutrients to usable ATP. Beyond energy, the broader NAD system participates in DNA-repair signaling and antioxidant defense. These effects on aging-related biology, energy metabolism, and cellular maintenance are mediated through specific enzymatic pathways; the pharmacology is well characterized in peer-reviewed literature, while real-world effect sizes vary by individual factors and consistency of use.

Why the ratio matters more than the label

Because NAD+ and NADH interconvert, the useful question is rarely "how much reduced NAD+ do I have" but "how is the pathway cycling." That framing is what makes the topic a pathway story rather than a single-number story, and it is the reason clinicians think in terms of the system rather than one metabolite.

Where NADH fits in longevity discussions

NADH and the NAD system show up in longevity conversations because the pathway touches energy production and cellular repair — two processes closely tied to how tissues age. It is a compound discussed in the longevity-protocol space, and PlexusDx addresses that category through its Longevity Protocols collection. See the relevant product page for current formulation details; this article stays on the science rather than a purchase path.

The genetic terrain underneath

Variants in genes such as FOXO3, SIRT1, and KLOTHO shape the baseline longevity-related biology that the NAD system operates within. These are pathway-level associations — they do not predict your response to any specific compound, but they describe the metabolic and cellular-maintenance landscape you are starting from. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights so you and your provider can see that landscape before any protocol decision. PlexusDx does not sell, distribute, or prescribe NADH itself; the genetic context is what it offers to keep the conversation informed.

Precursors versus the coenzyme itself

Much of the consumer conversation around NAD focuses on precursors — the building-block molecules the body can use to make NAD — rather than the coenzyme in its finished oxidized or reduced form. That distinction matters when reading product claims, because a supplement supplying a precursor is not the same as delivering NADH directly, and the two travel through different steps of the pathway.

Keeping these categories straight helps you interpret longevity marketing critically. The reduced form, the oxidized form, and the precursors are all part of one interconnected system, and no single label captures the whole picture. Anchoring your understanding to the pathway — how the pieces cycle and support one another — is more useful than fixating on any one molecule in isolation, and it keeps expectations grounded in biology rather than hype.

For anyone weighing a longevity protocol, that pathway-first framing is the most durable takeaway. Whether the conversation centers on the coenzyme, its reduced form, or a precursor, the underlying biology is shared — and understanding it equips you to read claims skeptically and to bring better questions to a provider. Science, not marketing, is the more reliable guide to what any of these molecules can and cannot do.

Frequently Asked Questions

Is NADH the same thing as NAD+?

They are two forms of the same coenzyme. NAD+ is the oxidized form and NADH is the reduced, electron-carrying form. Cells convert between them continuously as part of energy metabolism, so discussing "reduced NAD+" is really discussing one phase of a single dynamic cycle.

What does the reduced form do in cells?

NADH carries electrons into the mitochondrial pathway that generates cellular energy, connecting nutrient breakdown to ATP production. The wider NAD system also supports DNA-repair signaling and antioxidant defense. These roles are well documented in the literature, though how they translate to any individual varies with personal biology.

Why do longevity discussions focus on NAD?

Because the pathway sits at the intersection of energy production and cellular maintenance, both of which are central to how tissues age. That is why NAD and NADH appear so often in longevity content — the interest is in the pathway's role, calibrated to clinical literature rather than to testimonials.

How does genetic context relate to the NAD pathway?

It does not predict your response to any compound. Pathway-level variants in FOXO3, SIRT1, and KLOTHO describe the baseline longevity-related biology the NAD system works within, giving you and your provider upstream context that applies across longevity-protocol discussions rather than a prediction about a specific product.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.